Qlife Holding – CEO Interview

Sammanfattning

We have interviewed Qlife Holding’s CEO, Thomas Warthoe, about the developments during 2025 and how the company is positioning itself for the next phase. In the interview, we discuss the key events of the past year, the company’s main priorities for the next 6–12 months, and its longer-term strategic objectives.

The conversation also covers the rollout plan for Hipro products in Europe and the United States, the current status of the ongoing Hipro reverse takeover process, and the next steps in that work. In addition, we discuss the status of the Egoo PHE submission and what obtaining CE IVD approval for PHE testing could enable in both the short and long term.

Finally, we address how the proceeds from the rights issue are intended to be used, the company’s expected cash runway based on the current plan, and which milestones management considers most important heading into 2026.